This grant from the National Institute on Drug Abuse supports research on the roles of extracellular RNA carrier subclasses in biological processes relevant to substance use disorders (SUDs) and HIV infection. Researchers can explore mechanisms involving RNA carriers or develop technologies to study extracellular vesicles. Deadline: May 07, 2023.
Opportunity ID: 325779
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-20-147 |
| Funding Opportunity Title: | Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 25, 2020 |
| Last Updated Date: | Mar 25, 2020 |
| Original Closing Date for Applications: | May 07, 2023 |
| Current Closing Date for Applications: | May 07, 2023 |
| Archive Date: | Jun 12, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Special district governments Private institutions of higher education Small businesses City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities County governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this FOA is to encourage research investigating the roles of extracellular RNA (exRNA) carrier subclasses in biological processes relevant to substance use disorders (SUDs) and/or HIV infection, latency, or pathogenesis in the CNS. Applicants may propose to investigate biological mechanisms involving exRNA carrier subclasses, or propose to develop improved technologies to investigate extracellular vesicles or other exRNA carriers. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-147.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 325779 Full Announcement-PAR-20-147 -> PAR-20-147-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00260540 | Sep 13, 2020 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00269747 | Oct 28, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277700 | Nov 01, 2022 | May 07, 2023 | View |
Package 1
Mandatory forms
325779 RR_SF424_2_0-2.0.pdf
325779 PHS398_CoverPageSupplement_5_0-5.0.pdf
325779 RR_OtherProjectInfo_1_4-1.4.pdf
325779 PerformanceSite_2_0-2.0.pdf
325779 RR_KeyPersonExpanded_2_0-2.0.pdf
325779 PHS398_ResearchPlan_4_0-4.0.pdf
325779 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
325779 RR_Budget_1_4-1.4.pdf
325779 RR_SubawardBudget30_1_4-1.4.pdf
325779 PHS398_ModularBudget_1_2-1.2.pdf
325779 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
325779 RR_SF424_5_0-5.0.pdf
325779 PHS398_CoverPageSupplement_5_0-5.0.pdf
325779 RR_OtherProjectInfo_1_4-1.4.pdf
325779 PerformanceSite_4_0-4.0.pdf
325779 RR_KeyPersonExpanded_4_0-4.0.pdf
325779 PHS398_ResearchPlan_4_0-4.0.pdf
325779 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
325779 RR_Budget_3_0-3.0.pdf
325779 RR_SubawardBudget30_3_0-3.0.pdf
325779 PHS398_ModularBudget_1_2-1.2.pdf
325779 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
325779 RR_SF424_5_0-5.0.pdf
325779 PHS398_CoverPageSupplement_5_0-5.0.pdf
325779 RR_OtherProjectInfo_1_4-1.4.pdf
325779 PerformanceSite_4_0-4.0.pdf
325779 RR_KeyPersonExpanded_4_0-4.0.pdf
325779 PHS398_ResearchPlan_5_0-5.0.pdf
325779 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
325779 RR_Budget_3_0-3.0.pdf
325779 RR_SubawardBudget30_3_0-3.0.pdf
325779 PHS398_ModularBudget_1_2-1.2.pdf
325779 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
